American Liver Foundation Hosts National Legacy Gala Honoring Liver Health Leaders

Patients, families, thought leaders and business visionaries come together on October 13, 2022in New York

FAIRFIELD, NJ, October 12, 2022 /PRNewswire/ — The American Liver Foundation (ALF) National Legacy Gala will welcome patients and families, thought leaders, leading healthcare professionals, business visionaries and organizational partners from health, pharmaceutical and biotechnology on Thursday, October 13, 2022in Capital in New York City all to raise awareness and funds for those affected by liver disease.

“Liver disease affects approximately 100 million Americans, but most don’t even know they have it until it’s too late,” he said. Lorraine Stiehl, CEO, American Liver Foundation. “We are committed to reaching the undiagnosed and ensuring that those who already suffer from liver disease have the best treatment options and the best possible outcomes. On behalf of all those affected by liver disease , we extend our heartfelt thanks to everyone who made the 2022 National Legacy Gala possible.”

ALF National Legacy Gala, co-chairs are Bakari and Ellen Sellers. Mr. Sellers, a CNN political analyst and his wife Sellers Ellen RuckerCEO and co-owner, Rucker Roots, are parents of a child with pediatric liver disease. The president of the honorary committee of the National Heritage Gala is Richard J. Miller. Esq, a passionate liver advocate who received a transplant in May 2021. The evening at the Capital in New York City will include a cocktail reception, silent auction and dinner with a stunning presentation to our award winners who have made outstanding contributions to the liver community in the fields of biotechnology, medical innovation and philanthropy.

The co-presidents of the National Legacy Gala and the Bakari family and the family of liver patients Ellen Sellers shared, “As parents of a child born with life-threatening pediatric liver disease, our goal is to raise awareness and inspire donations for the prevention, treatment and cure of all liver disease.”

“It is indeed an honor to serve the American Liver Foundation this year as Chairman of the National Legacy Gala Honors Committee, and to recognize our distinguished honorees – Dr. Donald Jensendr. Allan Wolkoffand my friends, Susan and Michael Kerr – for their outstanding contributions to our liver community,” said Richard J. Miller, Esq. “I received my life-saving liver transplant a year ago, and without the people like our awardees who advance biotechnology, medical innovation and support these efforts through charitable donations , I and many others would not be alive today so that we could continue to lead healthy and productive lives.”

The 2022 award recipients include:

  • Donald JensenMD – Legacy AwardFor more than 25 years, Dr. Jensen served as an advisor to the American Liver Foundation, spearheading collaborative liver care efforts in Illinois and contributing its expertise to national ALF efforts. He served as Chairman of the Board and a member of the Medical Advisory Committee of the former ALF Great Lakes Division, where he twice received the Physician of the Year Award. Dr. Jensen has also served on the ALF National Board of Directors, as a passionate patient advocate for washington d.c., and as an avid fundraiser for ALF walks and challenge events. He is recognized for his contributions to liver disease locally, nationally and internationally.
  • Susan and Michael Kerr – Life Achievement Award— The Kerrs are proud supporters of the American Liver Foundation. Michael, a liver transplant recipient, became involved with the FAL in 2008 by joining the National Board of Directors. He is a member of the finance committee and served as chair until 2021. Susan, a living donor to her husband Michael, has also been actively involved in the FAL and together they have been unwavering supporters. Generous with their time and resources, their passion and commitment to the ALF has been integral to the foundation’s growth and success.
  • Allan WolkoffMD – Leadership Award—For more than 35 years of service, Dr. Allan Wolkoff demonstrated commitment to the mission of the American Liver Foundation. As a member of ALF’s Scientific Advisory Board from 1983 to 1986, he received the Outstanding Achievement Award in 1986. He then served on ALF’s Board of Directors from 2005 to 2013 and as Chairman of the Board of Directors from 2007 to 2011. In 2011, he received ALF’s most distinguished award, the George Jamieson Humanitarian Award, for his outstanding national contribution to those affected by hepatitis and other liver diseases. He also received the Distinguished Scientific Achievement Award from the ALF in 2012 for his contributions to liver disease research in the basic sciences or in its application to the prevention, treatment or cure of liver disease.

In addition to the evening’s tributes and awards, a variety of items will be available for silent, live auction, including sporting events, stays at locations around the world, and accessories. The silent auction will use the GiveSmart online auction platform, and pre-event and remote auctions will be available at LegacyGala22.givesmart.com.

For more information on the winners or the evening’s events, visit https://alfgala.org.

About liver disease:

Your liver is essential to your life. It is the largest solid internal organ in the body. It is about the size of a football and weighs around 3–3.5 pounds (1.36–1.59 kg). It is located on your right side, just below your rib cage. The liver performs many vital functions including filtering toxins from your blood, managing blood clotting, providing bile to digest fats, storing sugar for energy, converting extra glucose into glycogen, manufacturing protein for blood plasma and aid in digestion.

There are many types of liver diseases and conditions, the most common being hepatitis viruses, non-alcoholic fatty liver disease (NAFLD), autoimmune diseases, genetic diseases, cancer and others. More than 100 million people in the United States have some form of liver disease. About 4.5 million American adults (1.8%) have been diagnosed with liver disease. But an estimated 80 to 100 million adults in the United States have fatty liver disease, and many are unaware they have it. Research estimates that fatty liver disease is present in up to 75% of overweight people and in over 90% of people with severe obesity. Globally, it affects one billion people. In 2020, 51,642 adults in the United States died from liver disease (15.7 per 100,000 population). Find more information about liver disease.

About the American Liver Foundation

The American Liver Foundation is the nation’s largest nonprofit organization focused solely on promoting liver health and preventing disease. The American Liver Foundation accomplishes its mission in the fight against liver disease by funding scientific research, education of healthcare professionals, advocacy, education and support programs for patients and their families, and public awareness campaigns on liver wellness and disease prevention. The mission of the American Liver Foundation is to promote education, advocacy, support services, and research for the prevention, treatment, and cure of liver disease. For more information, visit www.liverfoundation.org or call: 1 800 GO LIVER (800-465-4837).

Facebook
Twitter
LinkedIn
Youtube
instagram

Contact: Julie Kimbrough
[email protected]
Direct call: 646-737-9409

SOURCE American Liver Foundation

Comments are closed.